TP63 and urothelial carcinoma: To better understand the clinical relevance of p63 expression in urothelial carcinomas, we analysed the relationship between p63 immunostaining and clinicopathological parameters of disease progression as well as patient outcome in a cohort of more than 2700 urothelial carcinomas in a tissue microarray (TMA) format.